• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP NEWS SCAN: More Saudi MERS; Under-reported Ehrlichia species

Shiloh

Editor, Senior Moderator
Source: http://www.cidrap.umn.edu/news-perspective/2016/03/news-scan-mar-29-2016

News Scan for Mar 29, 2016
More Saudi MERS; Under-reported Ehrlichia species

Filed Under:
MERS-CoV; Tick-borne Disease
[h=3]Saudi Arabia reports 1 new MERS case and 1 death[/h] Saudi Arabia's Ministry of Health (MOH) today reported one new MERS-CoV case in the southeastern city of Jazan and also announced the death of a previously reported patient.
The MERS-CoV (Middle East respiratory syndrome coronavirus) case in Jazan involves a 55-year-old Saudi man who is hospitalized in stable condition. He is not a healthcare worker, and his history of camel exposure is currently unknown, the MOH said. His infection is listed as "primary," meaning he did not contract the disease from another person.
The agency also reported the death of a 78-year-old Saudi woman in Al-Kharj. She was not a healthcare worker and had an underlying medical condition, the MOH said.
Today's update brings the MERS total in Saudi Arabia since 2012 to 1,361 cases, including 581 deaths. Sixteen cases remain active.
Mar 29 MOH update

[h=3]Ehrlichia species likely underreported as cause of tick-borne disease[/h] The tick-borne bacterium Ehrlichia ewingii is likely missed by diagnostic testing and has a higher prevalence and wider geographic range in the United States than previously thought, according to a study yesterday in Emerging Infectious Diseases.
A team of researchers evaluated samples collected from 4,177 patients with tick-borne disease between May 2013 and November 2014. Ten (9.2%) of 109 people with ehrlichiosis caused by an unidentified species were found to be infected with E ewingii.
Case-patients with E ewingii were from Missouri (4 cases), Indiana (3), Arkansas (1), New Jersey (1), and New York (1). All ten positive samples were collected between June and September. Though clinical disease caused by E ewingii has not been characterized, 5 patients with available records had signs or symptoms associated with tick-borne illness, including fever, thrombocytopenia, and joint pain. All infections resolved with doxycycline treatment.
The study marks the first time that E ewingii has been identified in New Jersey and Indiana. Both states are in the range of the bacterium's vector, Amblyomma americanum (the lone star tick), which is prevalent in the eastern and southeastern US.
During the study period, only 2% (31) of 1,518 reported ehrlichiosis cases in the United States had E ewingii as the cause, suggesting that infections due to the species often go undiagnosed because of successful antibiotic treatment, limited availability of adequate tests, and the assumption that ehrlichiosis cases are caused by the more common E chaffeensis, the authors said.
Mar 28 Emerg Infect Dis study
 
Back
Top Bottom